[Prognostic factors in kidney cancer].
Patard
Jean Jacques
JJ
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D002292:Carcinoma, Renal Cell / Q000401:mortality* / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000401:mortality* / Q000628:therapy*; D008954:Models, Biological; D009392:Nephrectomy; D011379:Prognosis
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D007376:Interleukin-2